Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TOREFORANT TARTRATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TOREFORANT TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HSV17TLD9C
Molecule Type:
Small molecule
Molecular Formula:
C50H70N12O6
Molecular Weight:
935.19
AlogP:
4.48
PSA:
69.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
EPELEUTON
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EPELEUTON
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRAXOPRODIL
(2)
Small molecule
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
Unknown
Investigational
Unknown
TRAXOPRODIL
×
Maximum Phase:
2
First Approval:
None
UNII:
UTC046R5HM
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO3
Molecular Weight:
327.42
AlogP:
2.8
PSA:
63.93
HBD:
3.0
HBA:
#RotB:
4.0
Source:
GLPG-0974
(2)
Small molecule
Free fatty acid receptor 2 antagonist
Unknown
Investigational
Unknown
GLPG-0974
×
Maximum Phase:
2
First Approval:
None
UNII:
X7REK61AIS
Molecule Type:
Small molecule
Molecular Formula:
C25H25ClN2O4S
Molecular Weight:
485.01
AlogP:
5.05
PSA:
77.92
HBD:
1.0
HBA:
#RotB:
8.0
Source:
C-1311
(2)
Small molecule
DNA topoisomerase II inhibitor
Unknown
Investigational
Unknown
C-1311
×
Maximum Phase:
2
First Approval:
None
UNII:
MZ4Y5H4OAB
Molecule Type:
Small molecule
Molecular Formula:
C20H22N4O2
Molecular Weight:
350.42
AlogP:
2.9
PSA:
69.87
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LY2624803
(2)
Small molecule
Histamine H1 receptor antagonist
Unknown
Investigational
Unknown
LY2624803
×
Maximum Phase:
2
First Approval:
None
UNII:
63J9EQ81YC
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AB-001
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AB-001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAGROCORAT
(2)
Small molecule
Glucocorticoid receptor modulator
Unknown
Investigational
Unknown
DAGROCORAT
×
Maximum Phase:
2
First Approval:
None
UNII:
OPM23UN90U
Molecule Type:
Small molecule
Molecular Formula:
C29H29F3N2O2
Molecular Weight:
494.56
AlogP:
6.16
PSA:
62.22
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FIPAMEZOLE
(2)
Small molecule
Adrenergic receptor alpha-2 antagonist
Unknown
Investigational
Unknown
FIPAMEZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
T5RCK09KHV
Molecule Type:
Small molecule
Molecular Formula:
C14H15FN2
Molecular Weight:
230.29
AlogP:
3.0
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
INARIGIVIR SOPROXIL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
INARIGIVIR SOPROXIL
×
Maximum Phase:
2
First Approval:
None
UNII:
365052M0DK
Molecule Type:
Small molecule
Molecular Formula:
C25H34N7O13PS
Molecular Weight:
703.62
AlogP:
0.27
PSA:
263.69
HBD:
4.0
HBA:
#RotB:
13.0
Source:
SENAPARIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SENAPARIB
×
Maximum Phase:
2
First Approval:
None
UNII:
MNZ4OP95CF
Molecule Type:
Small molecule
Molecular Formula:
C24H20F2N6O3
Molecular Weight:
478.46
AlogP:
1.77
PSA:
104.19
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZD2516
(2)
Small molecule
Metabotropic glutamate receptor 5 negative allosteric modulator
Unknown
Investigational
Unknown
AZD2516
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALANOSINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALANOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2CNI71214Y
Molecule Type:
Small molecule
Molecular Formula:
C3H7N3O4
Molecular Weight:
149.11
AlogP:
-1.23
PSA:
116.22
HBD:
3.0
HBA:
#RotB:
4.0
Source:
BO-653
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BO-653
×
Maximum Phase:
2
First Approval:
None
UNII:
2VSP9T5LRX
Molecule Type:
Small molecule
Molecular Formula:
C26H44O2
Molecular Weight:
388.64
AlogP:
7.82
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CRIDANIMOD
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CRIDANIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
X91E9EME19
Molecule Type:
Small molecule
Molecular Formula:
C15H11NO3
Molecular Weight:
253.26
AlogP:
2.24
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SODELGLITAZAR
(2)
Small molecule
Peroxisome proliferator-activated receptor agonist
Unknown
Investigational
Unknown
SODELGLITAZAR
×
Maximum Phase:
2
First Approval:
None
UNII:
6G973E04VI
Molecule Type:
Small molecule
Molecular Formula:
C23H21F4NO3S2
Molecular Weight:
499.55
AlogP:
7.12
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
VOXTALISIB
(2)
Small molecule
PI3-kinase class I inhibitor
Unknown
Investigational
Unknown
VOXTALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
CVL1685GPH
Molecule Type:
Small molecule
Molecular Formula:
C13H14N6O
Molecular Weight:
270.3
AlogP:
1.09
PSA:
102.48
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LENIOLISIB PHOSPHATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LENIOLISIB PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
3700M1H39Q
Molecule Type:
Small molecule
Molecular Formula:
C21H28F3N6O6P
Molecular Weight:
548.46
AlogP:
2.88
PSA:
83.48
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TOLEVAMER SODIUM
(2)
Small molecule
Toxin A binding agent
Unknown
Investigational
Unknown
TOLEVAMER SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
185M5I2ZZN
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LETEPRINIM POTASSIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LETEPRINIM POTASSIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Q06WU8JY4F
Molecule Type:
Small molecule
Molecular Formula:
C15H12KN5O4
Molecular Weight:
365.39
AlogP:
0.85
PSA:
129.97
HBD:
3.0
HBA:
#RotB:
5.0
Source:
DS-1971
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DS-1971
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PYRUVATE SODIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PYRUVATE SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
POD38AIF08
Molecule Type:
Small molecule
Molecular Formula:
C3H3NaO3
Molecular Weight:
110.04
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
K-134
(2)
Small molecule
Phosphodiesterase 3 inhibitor
Unknown
Investigational
Unknown
K-134
×
Maximum Phase:
2
First Approval:
None
UNII:
J9J6NK6W4U
Molecule Type:
Small molecule
Molecular Formula:
C22H29N3O4
Molecular Weight:
399.49
AlogP:
2.77
PSA:
94.66
HBD:
3.0
HBA:
#RotB:
7.0
Source:
SETROBUVIR
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
SETROBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
T5B2GI8F84
Molecule Type:
Small molecule
Molecular Formula:
C25H25FN4O6S2
Molecular Weight:
560.63
AlogP:
2.98
PSA:
145.24
HBD:
3.0
HBA:
#RotB:
5.0
Source:
SALIRASIB
(2)
Small molecule
RAS inhibitor
Unknown
Investigational
Unknown
SALIRASIB
×
Maximum Phase:
2
First Approval:
None
UNII:
MZH0OM550M
Molecule Type:
Small molecule
Molecular Formula:
C22H30O2S
Molecular Weight:
358.55
AlogP:
6.9
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
10.0
Source:
NELOTANSERIN
(2)
Small molecule
Serotonin 2a (5-HT2a) receptor inverse agonist
Unknown
Investigational
Unknown
NELOTANSERIN
×
Maximum Phase:
2
First Approval:
None
UNII:
4ZA73QEW2P
Molecule Type:
Small molecule
Molecular Formula:
C18H15BrF2N4O2
Molecular Weight:
437.24
AlogP:
4.78
PSA:
68.18
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ENMD-981693
(2)
Small molecule
Fibroblast growth factor receptor inhibitor
Unknown
Investigational
Unknown
ENMD-981693
×
Maximum Phase:
2
First Approval:
None
UNII:
J6U9WP10T7
Molecule Type:
Small molecule
Molecular Formula:
C22H16N4O4
Molecular Weight:
400.39
AlogP:
3.15
PSA:
99.17
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LY2940094
(2)
Small molecule
Nociceptin receptor antagonist
Unknown
Investigational
Unknown
LY2940094
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-275183
(2)
Small molecule
Tubulin stabiliser
Unknown
Investigational
Unknown
BMS-275183
×
Maximum Phase:
2
First Approval:
None
UNII:
UQC681JJIV
Molecule Type:
Small molecule
Molecular Formula:
C43H59NO16
Molecular Weight:
845.94
AlogP:
3.72
PSA:
239.75
HBD:
4.0
HBA:
#RotB:
8.0
Source:
MITOGLITAZONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MITOGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
29I7RP18RG
Molecule Type:
Small molecule
Molecular Formula:
C19H18N2O4S
Molecular Weight:
370.43
AlogP:
2.8
PSA:
85.36
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BGC-20-1531 FREE BASE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BGC-20-1531 FREE BASE
×
Maximum Phase:
2
First Approval:
None
UNII:
Z49JYU6T3P
Molecule Type:
Small molecule
Molecular Formula:
C26H24N2O6S
Molecular Weight:
492.55
AlogP:
4.66
PSA:
107.73
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MARDEPODECT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MARDEPODECT
×
Maximum Phase:
2
First Approval:
None
UNII:
R9Y8EY0G42
Molecule Type:
Small molecule
Molecular Formula:
C25H20N4O
Molecular Weight:
392.46
AlogP:
5.28
PSA:
52.83
HBD:
0.0
HBA:
#RotB:
5.0
Source:
RG-547
(2)
Small molecule
Cyclin-dependent kinase 1 inhibitor
Unknown
Investigational
Unknown
RG-547
×
Maximum Phase:
2
First Approval:
None
UNII:
T61871RKRI
Molecule Type:
Small molecule
Molecular Formula:
C18H21F2N5O4S
Molecular Weight:
441.46
AlogP:
1.41
PSA:
127.51
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ELSUBRUTINIB
(2)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Investigational
Unknown
ELSUBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
1487U1Q3IQ
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O2
Molecular Weight:
297.36
AlogP:
2.16
PSA:
79.19
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ARBEKACIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ARBEKACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACOZIBOROLE
(2)
Small molecule
Cleavage and polyadenylation specificity factor subunit inhibitor
Unknown
Investigational
Unknown
ACOZIBOROLE
×
Maximum Phase:
2
First Approval:
None
UNII:
2IOR2OO3GW
Molecule Type:
Small molecule
Molecular Formula:
C17H14BF4NO3
Molecular Weight:
367.11
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
151
152
153
154
155
156
157
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA